EMPLOYMENT AGREEMENT
Exhibit 99.1
This EMPLOYMENT AGREEMENT (“Agreement”) is made effective as of the date of signature by and between ENTREMED, INC., a Delaware corporation having its principal office at 0000 Xxxxxxx Xxxxxx Xxxxx, Xxxxxxxxx, XX 00000 (the “Company”) and Xxxxxxx X. Xxxxx, M.D. (the “Executive”).
FOR AND IN CONSIDERATION of the mutual premises, agreements and covenants contained herein, the parties hereto, intending to be legally bound, do hereby agree as follows:
1. Employment; Position and Duties.
Subject to the terms hereof, the Company hereby agrees to employ the Executive during the Term (as hereafter defined) to act as, and to exercise all of the powers and functions of its Vice President and Chief Medical Officer and to perform such acts and duties and to generally furnish such services to the Company and its subsidiaries (if any) as is customary for a senior management person with a similar position in like companies, including clinical research, clinical trial management, data management, and the management of U.S. and international regulatory affairs; and she shall report directly to the President and Chief Executive Officer (“CEO”) of the Company and have such specific powers, duties and responsibilities as the CEO, in consultation with and approval of the Board of Directors (the “Board”), shall from time to time reasonably prescribe. Executive hereby agrees to accept such employment and shall perform and discharge faithfully, diligently, and to the best of her abilities such duties and responsibilities and shall devote sufficient working time and efforts to the business and affairs of the Company and its subsidiaries.
2. Place of Employment.
While Executive is employed by the Company during the Term, Executive shall conduct her duties and responsibilities hereunder primarily from the executive offices located in Rockville, Maryland (except for routine and customary business travel), or from such other location as designated from time to time by the CEO. Executive may continue to perform her clinical duties and work on Company matters in North Carolina according to the schedule existing prior to the effective date of this Agreement, it being understood that under such existing schedule Executive normally performed services for the Company from the Research Triangle (Raleigh-Durham-Chapel Hill) area of North Carolina (the “Triangle”) on Monday morning where she maintains her clinical practice; subject to special scheduling needs of the Company, that Executive will accommodate scheduling of vacation, sick and personal leave in accordance with Company policy.
3. Compensation
a. Base Salary. While the Company employs Executive during the Term, the Company shall pay to Executive an annual base salary (“Base Salary”) of no less than $240,000, payable in accordance with the Company’s customary payroll policy for its executives.
b. Base Salary Adjustments. Executive’s Base Salary shall be reviewed at least annually in accordance with the Company’s customary practices for its executives. The Board or a committee thereof may make such adjustments, as it deems appropriate in its sole discretion. In making such adjustments the Board or a committee thereof may solicit and give consideration to the views of the CEO.
c. Incentive Compensation. While the Company employs Executive during the Term, Executive’s annual incentive compensation (“Incentive Compensation”) shall be targeted at 25% of base compensation, the exact amount of which shall be determined by the Board or a committee thereof in its sole discretion. Such bonus, if any, shall be paid within ninety (90) days following the last day of each fiscal year of the Company. In making such determinations, the Board or a committee thereof may solicit and take into consideration the views of the CEO.
d. Certain Other Benefits. While the Company employs Executive during the Term, Executive shall be entitled to participate in any and all employee benefit plans and arrangements which are available to senior executive officers of the Company, including without limitation, group medical, disability and life insurance plans. Executive shall also be afforded reasonable paid vacation and personal leave time pursuant to policies fixed by the Company.
e. Expenses. The Company shall pay or reimburse Executive for all reasonable business expenses actually paid or incurred by Executive while Executive is employed by the Company during the Term subject to reasonable documentation and in accordance with the Company’s business expense reimbursement policy. The Company shall continue to pay commutation, automobile and housing expenses from Executive’s residence in North Carolina to Rockville, MD and reasonable fees required to maintain her medical licenses and professional associations on the same basis as prior to the effective date of this Agreement; it being understood that under such existing arrangement the Company reimbursed Executive for reasonable costs associated with maintaining her clinical practice including malpractice insurance, license fees and fees for membership in appropriate organizations in an amount not to exceed $10,000 per year, travel on a commercial airline for regular weekly commuting from Executive’s home in the Triangle to Rockville, Maryland and from Rockville, Maryland to the Triangle, rental of a one-bedroom apartment for Executive’s use as needed in close proximity to the Company’s headquarters in Rockville, Maryland, and use of an automobile when in Rockville, Maryland.
4. Term.
The term of this Agreement shall be the period commencing on the date hereof and continuing for one year (the “Initial Term”); provided, however, that the Term of this Agreement shall be extended automatically for successive one year periods (each one-year extension a “Successor Term” and together with the Initial Term referred to herein as the “Term”) unless written notice of nonextension is provided by either party to the other party at least sixty (60) days prior to the end of the Initial Term or any Successor Term. The provision by the Company of a notice of nonextension shall be deemed to be termination without Cause under paragraph 8(d) hereof. In the event that this Agreement is not extended at the end of the Initial Term or any Successor Term and thereby terminates, only paragraphs 6, 7, 8(d), 8(g), 8(h), 8(i) and 11 shall survive such termination, except that Executive shall be entitled to receive compensation and benefits to the
extent expressly provided herein or by the terms of any of the Company’s compensation and benefit plans, programs or policies or as required by applicable law.
5. Stock Options.
In addition to all other stock options previously granted to Executive, as of the date of this Agreement the Company shall grant stock options to Executive covering 50,000 shares of common stock with a per share exercise price equal to the fair market value of a share of the Company’s common stock. Such options shall vest as to 25% of the covered shares immediately, and shall vest as to the remaining covered shares in cumulative 25% share increments on each of the first, second, and third anniversary dates of this Agreement, if Executive is then employed by the Company. Other periodic stock and incentive stock option grants to Executive, if any, while the Company employs Executive during the Term shall be determined by the Board or a committee thereof in its discretion. In the event of a termination pursuant to paragraph 8(d) hereof or a resignation pursuant to paragraph 9 hereof, all vested options held by Executive on the effective date of such termination or resignation shall be exercisable in accordance with the terms of such grants until the later of the date set forth in such grant or six (6) months following Executive’s date of termination, but in no event beyond the expiration date of the relevant option. All other unvested options shall expire in accordance with the terms of such grants. Except as set forth herein, the terms of the stock option grants under this paragraph 5 shall be otherwise in accordance with and subject to the terms of the Company’s 2001 Long Term Incentive Plan or successor plan and such terms and conditions as the Board or a committee thereof may specify.
6. Unauthorized Disclosure.
During the Term and at all times thereafter, Executive shall not, without the written consent of the Company, or except as required by applicable law, disclose to any person, other than a person to whom disclosure is reasonably necessary or appropriate in connection with the performance by Executive of her duties as an executive officer of the Company, any material confidential information obtained by Executive while in the employ of the Company with respect to the businesses of the Company or any of its subsidiaries, including but not limited to, operations, pricing, contractual or personnel data, products, discoveries, improvements, trade secrets, license agreements, marketing information, suppliers, dealers, principles, customers, or methods of distribution, or any other confidential information the disclosure of which knows, or in the exercise of reasonable care should know, will be damaging to the Company; provided, however, that confidential information shall not include any information known generally to the public or to persons in the industry of which the Company’s business is a part (in each case, other than as a result of unauthorized disclosure by Executive) or any information otherwise considered by the Company not to be confidential.
7. Indemnification.
a. The Company shall indemnify and hold harmless Executive if she is made a party, or threatened to be made a party, to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative, or investigative (a “Proceeding”), because she is or was an officer or director of the Company or any of its subsidiaries, affiliates, or
successors, or because she is or was serving in a fiduciary capacity with respect to employee benefit plans of the Company, whether or not the basis of such Proceeding is alleged action in an official capacity or otherwise, against all Expenses incurred or suffered by her in connection with such Proceeding to the fullest extent authorized by the General Corporation Law of the State of Delaware and any other applicable law in effect from time to time, and such indemnification shall continue as to Executive even if she ceases to be an officer or director or is no longer employed by the Company, and shall inure to the benefit of Executive’s heirs, executors and administrators.
b. As used in this Agreement, the term “Expenses” shall include, without limitation, damages, losses, judgments, liabilities, fines, penalties, excise taxes, settlements and reasonable costs, reasonable attorneys’ fees, reasonable accountants’ fees, and reasonable disbursements and costs of attachment or similar bonds, investigations, and any reasonable expenses of establishing a right to indemnification under this Agreement.
c. Expenses incurred by Executive in connection with any Proceeding shall be paid by the Company upon presentation of appropriate documentation and a giving by Executive of any undertakings required by applicable law.
8. Termination.
a. Termination Upon Death. If Executive dies while employed by the Company during the Term, her estate shall be entitled to receive payment of Base Salary through the last day of the six (6) months following the month in which her death occurred, payable over six (6) months at the Company’s normal pay periods. If, in respect of the fiscal year in which Executive dies the Board or a committee thereof determines in its discretion that she would otherwise have been entitled to receive Incentive Compensation under subparagraph 3(c) by reason of the operations of the Company during such fiscal year, Executive’s estate shall be entitled to receive a pro rata portion of her Incentive Compensation for such fiscal year. Such pro rata portion shall equal the product of (x) the full amount of such Incentive Compensation, and (y) a fraction, the numerator of which is the number of days in the fiscal year of Executive’s death prior to the date of death, and the denominator of which is the total number of days in such fiscal year.
b. Termination Upon Disability. The Company may terminate Executive’s employment hereunder during the Term at the end of any calendar month in the event of her Disability by giving to Executive written notice of termination. In the event of any such termination pursuant to this subparagraph 8(b), Executive shall be entitled to receive her Base Salary, payable in accordance with the Company’s customary payroll policy for it executives, through the last day of the six (6) months following the month in which the date of termination occurred. If in respect of the fiscal year in which Executive’s employment terminates pursuant to this subparagraph 8(b) the Board or a committee thereof determines in its discretion that she would otherwise have been entitled to receive Incentive Compensation under subparagraph 3(c) by reason of the operations of the Company during such fiscal year, Executive shall be entitled to receive a pro rata portion of her Incentive Compensation for such year. Such pro rata portion shall equal the product of (x) the full amount of such Incentive Compensation, and (y) a fraction, the numerator of which is the number of days in the fiscal year of Executive’s termination on
account of Disability prior to the date of termination, and the denominator of which is the total number of days in such fiscal year.
c. Termination for Cause. The Company may terminate Executive’s employment hereunder at any time during the Term for Cause by giving to Executive written notice of termination that specifies the reasons for and date of termination. Upon any such termination for Cause under this subparagraph 8(c), the Company shall pay to her Base Salary through the date of termination, and the Company shall have no further obligations under this Agreement.
d. Termination Without Cause. The Company may terminate Executive’s employment with the Company at any time during the Term, for any reason and without Cause, by giving her prior written notice, which specifies the date of termination. Until the effective date of any such termination, the Company shall continue to pay to her the full compensation specified in this Agreement. Following the date of termination, Executive shall make herself reasonably available to members of the Board, the CEO, and other senior managers and officers of the Company to assist in the transition of responsibilities and information to others and to facilitate the orderly conduct of business operations. Upon termination, the Company shall have no other financial obligations to Executive under any compensation or benefit plan, program or policy and Executive’s participation in the Company’s compensation and benefit plans, programs and policies shall cease as of the date of Executive’s termination except as set forth herein or as expressly provided under the terms of any such plans, programs or policies, or as required by applicable law. If Executive is terminated pursuant to this subparagraph 8(d), the Company shall (i) pay Executive a severance amount equal to six (6) months Base Salary over the following six (6) months at the Company’s normal pay periods, and (ii) provide Executive, at no charge to Executive, COBRA continuation coverage under the Company’s health insurance program for a period of six (6) months or until she has obtained substantially equivalent new coverage, as determined by the Board or a committee thereof in its discretion, through successor employment, whichever occurs sooner. If, during the Term, Executive is terminated without Cause within twelve (12) months of the effective date of this Agreement, the phrase “six (6) months” in the preceding sentence shall be replaced in each place it appears with the phrase “twelve (12) months.” If, in respect of the fiscal year in which Executive’s employment terminates pursuant to this subparagraph 8(d), the Board or a committee thereof determines in its discretion that she would otherwise have been entitled to receive Incentive Compensation under subparagraph 3(c) by reason of the operations of the Company during such fiscal year, Executive shall be entitled to receive a pro rata portion of her Incentive Compensation for such year. Such pro rata portion shall equal the product of (x) the full amount of such Incentive Compensation, and (y) a fraction, the numerator of which is the number of days in the fiscal year of Executive’s termination without Cause prior to the date of termination, and the denominator of which is the total number of days in such fiscal year.
e. Resignation for Other than Good Reason. Executive may voluntarily terminate her employment with the Company during the Term for any reason upon at least sixty (60) days prior written notice, which specifies the effective date of termination. Until the effective date of such termination, the Company shall continue to pay her the full compensation specified in this Agreement, provided she continues to perform her duties during this period. Thereafter, the Company shall have no further obligations to her under this Agreement. This subparagraph 8(e) shall not apply to Executive’s resignation for Good Reason pursuant to paragraph 9 hereof.
f. No Mitigation. The parties hereto acknowledge and agree that, in the event Executive’s employment with the Company is terminated pursuant to this paragraph 8, she shall not be required to mitigate her damages by affirmatively seeking other employment. Further, except as provided in subparagraph 8(d)(ii) above, the amount of any payment or benefit provided for in this Agreement shall not be reduced by any compensation earned by her or benefit provided to her as the result of employment by another employer or otherwise.
g. Non-Competition. For a period of twelve (12) months after termination of Executive’s active employment with the Company, Executive shall not, as an individual, principal, agent, employee, consultant or otherwise, directly or indirectly, in the United States or with respect to any company or entity in Europe or Canada with whom Executive or the Company has concluded partnership, licensing, joint research and development or other similar business agreements on behalf of and during her employment with the Company, render any services to any firm or company or any division or subsidiary of any firm or company, engaged in the research, development or commercialization of compounds, analogs or derivatives of those compounds which compete directly with those being researched, developed and or commercialized by the Company during the Term ; provided, however, that in the case of any of the foregoing, she may be employed by such a competing business provided that she does not work in or furnish confidential information to the section or division of the competing business that is engaged in such research, development or commercialization. Moreover, for a period of twelve (12) months after the termination of Executive’s employment with the Company, Executive shall not take any action, without the prior written consent of the Company, to assist Executive’s successor employer or any other entity in recruiting or hiring any other employee who was an employee of the Company during Executive’s employment. This prohibition includes (i) identifying to such successor employer or its agents or such other entity, the person or persons who have special knowledge concerning the Company or its inventions, processes, methods or confidential affairs, and (ii) commenting to Executive’s successor employer or its agents or such other entity about the quantity or work, quality of work, special knowledge or personal characteristics of any person who is still employed by the Company. Executive also agrees that she will not provide such information to a prospective employer or to an executive search firm during interviews preceding possible employment.
h. Non-Disparagement. During the Term and thereafter, Executive shall not communicate negatively about or otherwise disparage the Company or its products or each and any of the released parties described in subparagraph 8(i) in any way whatsoever except as may be required for truthful sworn testimony or in connection with a legal or administrative proceeding, report, claim or dispute. The Company, acting in its official capacity, shall not make any public false, disparaging or derogatory statements in connection with or concerning Executive’s service to the Company except as may be required for truthful sworn testimony or in connection with a legal or administrative proceeding, report, claim or dispute. After termination, in the event Executive materially breaches any of the conditions set forth herein or in any other paragraph of this Agreement, the Company may discontinue the provision of any payment or benefits to her under this Agreement, and in such event she shall forfeit her entitlement to any further termination payments or benefits under this Agreement.
i. Release. In consideration of Executive’s receipt of severance benefits subject to and in accordance with subparagraphs 8(b) and (d) and paragraph 9 of this Agreement, Executive
agrees that, upon her first receipt and acceptance of any such benefits, she shall have released and forever discharged the Company, its subsidiaries and affiliates, successors and assigns, predecessors and all of their respective officers, directors, employees and agents and employee benefits plans from all claims, demands, liabilities and causes of action arising out of facts or occurrences arising or occurring at any time up to and including the time of Executive’s termination or resignation, whether known or unknown, and the parties hereto contemplate that this release shall be broadly construed.
9. Resignation for Good Reason.
If Executive has Good Reason during the Term, Executive may resign at any time during the Term by providing at least sixty (60) days prior written notice to the Company that specifies the reason for, and the effective date of, her resignation. If Executive resigns during the Term for Good Reason, such resignation shall be deemed a Termination without Cause under subparagraph 8(d) hereof and Executive shall receive the compensation and benefits provided under subparagraph 8(d) hereof as if she had been terminated without Cause.
10. Definitions.
a. “Cause” shall mean Executive’s (i) habitual drunkenness or drug addiction, (ii) material failure to perform and discharge her duties and responsibilities hereunder, (iii) misconduct that is materially and significantly injurious to the Company, (iv) conviction of a felony involving the personal dishonesty of Executive or moral turpitude, (v) conviction of any crime or offense involving the property of the Company or (vi) material breach of Executive’s obligations under this Agreement.
b. “Disability” shall mean the Executive’s incapacity due to physical or mental illness which prevents the proper performance of Executive’s duties as set forth herein or established pursuant hereto for ninety (90) days in any twelve (12) month period of the Term. A qualified independent physician selected by the Company and approved by the Executive shall determine any questions as to the existence or extent of illness or incapacity of Executive, upon which the Company and Executive cannot agree. The determination of such physician certified in writing to the Company and to the Executive shall be final and conclusive for all purposes of this Agreement. For purposes of the disability provisions of this Agreement, if the Executive is unable to act on her own behalf due to incapacity, any person legally authorized to do so may act on the Executive’s behalf.
c. “Good Reason” shall mean the occurrence of any of the following events during the Term: (A) the assignment to Executive of any duties inconsistent in any material respect with Executive’s position, authority, duties or responsibilities as of the commencement of the Term or any other action by the Company which results in a diminution in any material respect in such position, duties or responsibilities, excluding for this purpose an isolated and inadvertent action not taken in bad faith that is remedied by the Company promptly after receipt of written notice thereof given by Executive; (B) a reduction by the Company in Executive’s annual Base Salary as in effect on the date hereof or subsequently in effect hereunder, except as agreed to by Executive; (C) the failure by the Company to continue to provide Executive with benefits substantially similar to those enjoyed by her under any of the Company’s pension, life insurance,
medical, health and accident, disability or other welfare plans in which she was participating as of the commencement of the Term or subsequently in effect hereunder, unless such change was applicable to all senior executives of the Company; (D) the failure by the Company to pay to Executive any deferred compensation when due under any deferred compensation plan or agreement applicable to her; or (E) the failure by the Company to honor in any material respect the terms and provisions of this Agreement.
11. Miscellaneous.
a. Assignments and Binding Effect. The respective rights and obligations of the parties under this Agreement shall be binding upon the parties hereto and their heirs, executors, administrators, successors, and assigns, including, in the case of the Company, any other corporation or entity with which the Company may be merged or otherwise combined and, in the case of Executive, her estate or other legal representatives.
b. No Assignment of Benefits. Except as otherwise provided herein or by applicable law, no right or interest of the Executive under this Agreement shall be assignable or transferable, in whole or in part, either directly or by the operation of law or otherwise, including without limitation execution, levy, garnishment, attachment, pledge or in any manner; no attempted transfer thereof shall be effective.
c. Governing Law. This Agreement shall be governed as to its validity, interpretation and effect by the laws of the State of Maryland, without reference to its conflict of laws provisions.
d. Severability. In the event that any provision or portion of this Agreement shall be determined to be invalid, illegal, or unenforceable for any reason, the remaining provisions and portions of this Agreement shall remain in full force and effect to the fullest extent permitted by law. Such invalid, illegal or unenforceable provision(s) shall be deemed modified to the extent necessary to make it (them) valid, legal, and enforceable.
e. Withholding. All amount payable hereunder shall be paid net of any applicable withholding required under federal, state or local laws and any additional withholding to which Executive has agreed.
f. Entire Agreement; Amendments. This Agreement constitutes the entire Agreement and understanding of the Company and Executive with respect to the terms of Executive’s employment with the Company and supersedes all prior discussions, understandings and agreements with respect thereto except to those agreements relating to the assignment of patents and inventions and a Combined Non-disclosure and Patent Employee Agreement to which Executive acknowledges signing which will remain in effect.
g. Captions. All captions and headings used herein are for convenient reference only and do not form part of this Agreement.
h. Waiver. No provision of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing and signed by the Executive and the Board or its delegate. The failure of the Company or the Executive to insist upon strict
compliance with the terms of this Agreement or the failure of the Company or the Executive to assert any right the Company or the Executive may have hereunder shall not be deemed a waiver of such provision or right or any other provision of this Agreement.
i. Notice. Any notice or communication required or permitted under this Agreement shall be made in writing and shall be delivered by hand, or mailed by registered or certified mail, return receipt requested, first call postage prepaid, addressed as follows:
| If to Executive: | ||||||
| Xxxxxxx X. Xxxxx, M.D. | ||||||
| c/o EntreMed, Inc. | ||||||
| 0000 Xxxxxxx Xxxxxx Xxxxx | ||||||
| Xxxxxxxxx, Xxxxxxxx 00000 | ||||||
| If to the Company: | ||||||
| EntreMed, Inc. | ||||||
| 0000 Xxxxxxx Xxxxxx Xxxx | ||||||
| Xxxxxxxxx, Xxxxxxxx 00000 | ||||||
| Attn.: General Counsel | ||||||
j. Counterparts. This Agreement may be executed in counterparts, each of which shall constitute one and the same agreement.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of December 1, 2004.
| /s/ Xxxxxxx X. Xxxxx | ||||||
| Xxxxxxx X. Xxxxx | ||||||
| Executive | ||||||
| EntreMed, Inc. | ||||||
| By: | /s/ Xxxxx X. Xxxxx | |||||
| Xxxxx X. Xxxxx | ||||||
| President and Chief Executive Officer | ||||||
